Carregando…
Todas as empresas daqui passadas pelas mesmas cinco verificações sobre crescimento e geração de caixa. Descreve o segmento como ele se divulga hoje — não qual destas comprar.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | C | US$ 50,4B | US$ 43,21 | 100,49 | US$ 17,2B | 2,9% |
| HLN | Haleon plc | B+ | US$ 40,7B | US$ 9,09 | 18,33 | US$ 14,8B | 15,1% |
| ZTS | Zoetis Inc. | C+ | US$ 33,5B | US$ 82,57 | 13,92 | US$ 9,5B | 26,4% |
| TAK | Takeda Pharmaceutical Company Limited | A | US$ 33,5B | US$ 20,86 | 48,79 | US$ 29,8B | 0,9% |
| UTHR | United Therapeutics Corporation | C+ | US$ 25,4B | US$ 595,58 | 22,48 | US$ 3,2B | 38,6% |
| VTRS | VIATRIS INC. | D | US$ 24,1B | US$ 21,06 | — | US$ 14,7B | -23,9% |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | A+ | US$ 17,6B | US$ 174,35 | 25,87 | US$ 3,7B | 19,0% |
| ELAN | Elanco Animal Health Incorporated | A | US$ 13,2B | US$ 26,48 | — | US$ 5,1B | -2,9% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B | US$ 12,4B | US$ 14,83 | 20,77 | US$ 3,5B | 4,4% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A+ | US$ 8,1B | US$ 95,80 | 73,13 | US$ 946M | 11,6% |
| ALKS | Alkermes plc. | C | US$ 8B | US$ 47,88 | — | US$ 1,8B | -0,0% |
| AMRX | Amneal Pharmaceuticals, Inc. | C | US$ 7,6B | US$ 21,72 | 51,71 | US$ 3,2B | 4,2% |
| LNTH | LANTHEUS HOLDINGS, INC. | B+ | US$ 6,6B | US$ 101,58 | 25,08 | US$ 1,6B | 17,3% |
| LQDA | LIQUIDIA CORPORATION | A | US$ 5B | US$ 55,19 | — | US$ 621,9M | -15,1% |
| HIMS | HIMS & HERS HEALTH, INC. | C- | US$ 4,9B | US$ 20,81 | — | US$ 2,9B | -6,7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | US$ 4,1B | US$ 31,78 | — | US$ 0,00 | — |
| BHC | Bausch Health Companies Inc. | A | US$ 3,1B | US$ 8,35 | — | US$ 11,1B | -7,6% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | US$ 3B | US$ 16,51 | — | US$ 368,3M | -1,8% |
| RGC | REGENCELL BIOSCIENCE HOLDINGS LIMITED | sem nota | US$ 2,7B | US$ 5,45 | — | — | — |
| HCM | HutchMED (China) LIMITED | D | US$ 2,6B | US$ 15,04 | — | US$ 549,1M | 3,3% |
| PRGO | Perrigo Company plc | F- | US$ 2,3B | US$ 16,56 | — | US$ 4,1B | -43,3% |
| TRLV | TRULIEVE CANNABIS CORP. | F | US$ 2,3B | US$ 11,24 | — | US$ 1,1B | -41,3% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | US$ 2,1B | US$ 44,17 | 13,63 | US$ 1,2B | 13,3% |
| ETON | ETON PHARMACEUTICALS, INC. | A+ | US$ 2B | US$ 68,42 | — | US$ 141,1M | 35,3% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | B | US$ 2B | US$ 7,65 | — | US$ 961,5M | -37,4% |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | B | US$ 1,7B | US$ 29,42 | — | US$ 865,1M | -5,1% |
| ANIP | ANI PHARMACEUTICALS, INC | B+ | US$ 1,5B | US$ 71,23 | 14,22 | US$ 1B | 11,2% |
| ALVO | ALVOTECH | B | US$ 1,5B | US$ 4,93 | 49,25 | US$ 586,3M | 4,8% |
| PCRX | PACIRA BIOSCIENCES, INC. | B | US$ 1,5B | US$ 36,47 | 39,22 | US$ 743,3M | 5,1% |
| PAHC | Phibro Animal Health Corporation | B | US$ 1,4B | US$ 35,13 | 14,00 | US$ 1,5B | 6,7% |
| CRON | CRONOS GROUP INC. | A | US$ 1,3B | US$ 3,46 | 20,32 | US$ 206,2M | 28,0% |
| AMPH | Amphastar Pharmaceuticals, Inc. | B+ | US$ 1,2B | US$ 28,61 | 13,06 | US$ 745,8M | 13,3% |
| HROW | Harrow, Inc. | D- | US$ 1,1B | US$ 29,30 | — | US$ 303,3M | -9,4% |
| BGM | BGM Group Ltd | F- | US$ 985,4M | US$ 8,70 | — | US$ 47,9M | -44,2% |
| IRWD | IRONWOOD PHARMACEUTICALS INC | C+ | US$ 804,6M | US$ 4,86 | 5,40 | US$ 400,3M | 37,4% |
| COLL | Collegium Pharmaceutical, Inc. | B | US$ 770,5M | US$ 24,80 | 24,80 | US$ 815,2M | 4,7% |
| TKNO | ALPHA TEKNOVA, INC. | B- | US$ 541,6M | US$ 8,61 | — | US$ 46M | -34,8% |
| EOLS | EVOLUS, INC. | B | US$ 492,1M | US$ 7,44 | — | US$ 325,5M | -9,6% |
| KMDA | KAMADA LTD | C+ | US$ 469,6M | US$ 8,14 | 18,93 | US$ 196,9M | 13,6% |
| AQST | Aquestive Therapeutics, Inc. | D | US$ 449,3M | US$ 3,58 | — | US$ 48,8M | -162,3% |
| TLRY | Tilray Brands, Inc. | C- | US$ 385M | US$ 2,61 | — | US$ 963,1M | -17,1% |
| EBS | EMERGENT BIOSOLUTIONS INC. | D | US$ 310,3M | US$ 6,04 | — | US$ 649,1M | -40,2% |
| EVO | Evotec SE | F- | US$ 304,9M | US$ 1,72 | — | US$ 836,2M | -26,0% |
| ACB | AURORA CANNABIS INC | D- | US$ 280,9M | US$ 5,05 | 176,32 | US$ 225,8M | -29,9% |
| BIOA | BIOAGE LABS, INC. | F- | US$ 268,9M | US$ 5,85 | — | US$ 8,6M | -1.253,6% |
| CGC | Canopy Growth Corporation | C- | US$ 256,3M | US$ 0,61 | — | US$ 219,2M | -87,0% |
| LFCR | LIFECORE BIOMEDICAL, INC. | F | US$ 242,4M | US$ 6,40 | — | US$ 128,9M | -30,0% |
| SIGA | Siga Technologies INC | F | US$ 225,6M | US$ 3,14 | — | US$ 52,4M | 1,3% |
| INCR | INTERCURE LTD. | C- | US$ 219,8M | US$ 4,02 | — | US$ 86,4M | -13,2% |
| ADCT | ADC Therapeutics SA | C | US$ 203,6M | US$ 1,60 | — | US$ 84,9M | -95,7% |
| ANIK | Anika Therapeutics, Inc. | B- | US$ 186,3M | US$ 13,91 | — | US$ 123,4M | -1,4% |
| GLAS | Glass House Brands Inc. | F- | US$ 165,5M | US$ 1,90 | — | US$ 152,9M | -33,7% |
| AKBA | AKEBIA THERAPEUTICS, INC. | D | US$ 158M | US$ 0,57 | — | US$ 197,2M | -22,6% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | F- | US$ 136,3M | US$ 1,05 | — | US$ 352M | -38,4% |
| DERM | Journey Medical Corp | C- | US$ 125,7M | US$ 4,46 | — | US$ 68,2M | -9,0% |
| CRDL | Cardiol Therapeutics Inc. | sem nota | US$ 100,8M | US$ 1,01 | — | — | — |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | US$ 94,8M | US$ 6,33 | — | US$ 39,9M | -27,4% |
| INM | INMED PHARMACEUTICALS INC. | F- | US$ 85,5M | US$ 15,56 | — | US$ 4,5M | -292,1% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | US$ 81,3M | US$ 0,85 | — | US$ 185,5M | -9,6% |
| ZYBT | Zhengye Biotechnology Holding Limited | D | US$ 72,3M | US$ 1,53 | — | US$ 17,5M | -60,0% |
| CTOR | Citius Oncology, Inc. | sem nota | US$ 51,7M | US$ 0,56 | — | — | — |
| SCYX | SCYNEXIS INC | F- | US$ 34,1M | US$ 3,43 | — | US$ 18,9M | -53,5% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | US$ 28,7M | US$ 7,13 | — | US$ 72,6M | -7,8% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | D- | US$ 22,7M | US$ 0,53 | — | US$ 3,9M | -114,3% |
| TXMD | TherapeuticsMD, Inc. | F- | US$ 21,4M | US$ 1,85 | — | US$ 3,3M | -6,6% |
| AYTU | AYTU BIOPHARMA, INC. | C | US$ 19,7M | US$ 1,82 | — | US$ 57,6M | -24,8% |
| RDHL | REDHILL BIOPHARMA LTD. | F | US$ 17,9M | US$ 0,40 | — | -US$ 3,7M | -72,5% |
| TLPH | TALPHERA, INC. | D- | US$ 15M | US$ 1,05 | — | US$ 1K | -1.465.800,0% |
| BFRI | Biofrontera Inc. | B- | US$ 13,9M | US$ 0,93 | — | US$ 46,2M | -13,8% |
| SBFM | Sunshine Biopharma Inc. | D- | US$ 10,7M | US$ 2,76 | — | US$ 35,3M | -16,5% |
| CABR | Caring Brands, Inc. | F- | US$ 9,2M | US$ 0,88 | — | US$ 4,2K | -183.255,2% |
| IMCC | IM Cannabis Corp. | D | US$ 7,2M | US$ 0,56 | — | US$ 32,8M | -40,1% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | C- | US$ 6,2M | US$ 1,23 | — | US$ 23,5M | -7,6% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | sem nota | US$ 5,4M | US$ 5,32 | — | — | — |
| GELS | Gelteq Limited | D- | US$ 4M | US$ 0,43 | — | US$ 116,4K | -4.011,9% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | sem nota | US$ 3,4M | US$ 2,28 | — | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | US$ 2,8M | US$ 2,89 | — | US$ 1,1M | -545,2% |
| YCBD | cbdMD, Inc. | D- | US$ 1,6M | US$ 0,39 | — | US$ 20,9M | -13,8% |
| IXHL | Incannex Healthcare Inc. | F- | US$ 993,5K | US$ 1,98 | — | US$ 0,00 | — |
| UPC | Universe Pharmaceuticals INC | D- | US$ 907K | US$ 1,61 | — | US$ 17,9B | -20,6% |
| PRFX | PRF Technologies Ltd. | B- | US$ 629,5K | US$ 0,76 | — | US$ 17K | -29.541,2% |
| AKAN | Akanda Corp. | F | US$ 50,4K | US$ 0,73 | — | US$ 258,1K | -19.775,5% |
| INDV | Indivior Pharmaceuticals, Inc. | A | — | US$ 28,15 | — | US$ 1,4B | 32,8% |
| OPTH | Optimi Health Corp. | sem nota | — | US$ 2,19 | — | — | — |
Fundamentos de documentos entregues à SEC, preços da última coleta de dados de mercado. Ordene por qualquer coluna; empresas sem número vão para o fim nos dois sentidos.
Ordenado por valor de mercado, do maior para o menor; clique em qualquer coluna para reordenar. Empresas sem número vão para o fim nos dois sentidos, porque um P/L faltando significa prejuízo e não que esteja barata. Nada aqui é recomendação.